OM DENNE EPISODE

Engelsk
USA

UDSKRIFT 🔗

SØG BLANDT TIDLIGERE EPISODER

Søg efter gamle afsnit af Inside MedTech Innovation.

ANDRE EPISODE I DENNE PODCAST

Only 2% of sickle cell patients who could benefit from blood therapy actually receive it, despite it being first-line treatment. Marketing in medical devices isn't about jingles or promotions. It's about looking at data, drawing hypotheses, testing them, and ensuring every claim you make is scienti…
The Stanford Mussallem Center for Biodesign has trained innovators whose inventions have touched over 18 million lives while they were still in training. Most people think breakthrough innovation is magic or unpredictable. Dr. Josh Makower proved otherwise. As co-founder of the Stanford Mussallem C…
FDA commissioners come and go, but career civil servants are always there, applying the rules without financial conflicts of interest. Dr. Robert Califf served as FDA Commissioner twice, making him one of the most experienced regulatory leaders in healthcare history. Before FDA, he built the world'…
Dr. Bob Gabbay has spent decades at the intersection of diabetes research, clinical care, and technology innovation. From leading the Joslin Diabetes Center to serving as Chief Scientific and Medical Officer at the American Diabetes Association, he witnessed the field transform from sharpening need…
Ansvarsfraskrivelse: Podcasten og kunstværket, der er indlejret på denne side, er fra Shannon Lantzy, som tilhører dens ejer og ikke er tilknyttet eller godkendt af Listen Notes, Inc.